We have a mission!

PulseCath® is focused on developing ground-breaking technologies designed to assist the life sustaining pumping functions of the failing heart.

Take a look at our products

Now also available in the
App Store, download here:

SEE OUR

Facts & Figures

  • Registrations

    > 50 countries approved registrations

  • Cases

    > 175 shared cases on LinkedIn; > 400 reported cases

  • > 1.300 iVAC 2L sold

    > 35 distributor agreements

  • Hospitals

    > 45 hospitals use iVAC 2L on a regular base; > 9 Centers of Excellence.

  • Patients

    > 600 patients world wide treated by iVAC 2L

  • Clinical evidence

    > 30 publications

  • Indication

    The iVAC 2L is intended for use in patients with impaired left ventricular function which require left ventricular mechanical circulatory support for up to 24 hours

    • DISTRIBUTORS

    All over the world

    Grow with us!Take a look at our list of distributors

    MEET OUR

    Medical advisors

    Clinical programme supported by leading cardiologists

    THIS IS

    Our team

    Case-in-a-box congress - video 7

    Case-in-a-box congress - video 6

    Case-in-a-box congress - video 5

    Case-in-a-box congress - video 4

    Case-in-a-box congress - video 3

    Case-in-a-box congress - video 2

    Case-in-a-box congress - video 1

    Case-in-a-box number 2: Al Qassimi Hospital February 2023

    Case-in-a-box number 1: Al Qassimi Hospital February 2023

    iVAC 2L Procedure Steps

    iVAC 2L Setup

    iVAC 2L Trouble Shooting

    iVAC 2L Clinical Effect

    Complete webinar

    Home

    Session